Company profile

Nuvectis Pharma, Inc. insider acquisitions

Company CIK 0001875558 · Reported insider acquisitions and filing context.

Company filings at SEC ↗
NVCT · Nasdaq

These are company listings. A transaction is linked to a particular security only when the filing provides enough information.

Company activity summary

By transaction date, as of October 22, 2026.

7 days30 days90 daysOverlapping periods · securities and currencies kept separate

No records are loaded for this 30-day transaction window. This does not establish that no transactions occurred.

Known purchase value sums available amounts for non-derivative purchases only. Missing amounts are excluded. “Currency not specified” does not establish that the amounts share a currency. These summaries use all matching loaded records, while the timeline below covers only the current page.

Transaction timeline

Who reported an acquisition, and when the transaction occurred.

Reported acquisitions by transaction dateEach row is a reporting owner. Select a marker to open its transaction details. Jointly reported transactions appear for each associated reporting owner, without dividing quantities or amounts.BENTSUR RONBENTSUR RONSanchez JuanSanchez JuanKaplan Matthew L.Kaplan Matthew L.Mosseri Marlio CharlesMosseri Marlio CharlesBENTSUR RON · November 5, 2025 · Purchase · Common StockSanchez Juan · November 5, 2025 · Purchase · Common StockKaplan Matthew L. · November 5, 2025 · Purchase · Common StockSanchez Juan · September 22, 2025 · Stock award · Common StockMosseri Marlio Charles · October 27, 2025 · Purchase · Common StockMosseri Marlio Charles · October 24, 2025 · Purchase · Common StockMosseri Marlio Charles · October 23, 2025 · Purchase · Common StockSep 22, 2025Nov 5, 2025
PurchaseStock awardGift receivedExercise / conversionConversionOther acquisition

7 dated transactions · 4 of 4 reporting owners shown. Select one owner to focus the chart.

View timeline as a table
Transaction dateCompany / securityReporting ownersAcquisition type
Nov 5, 2025Nuvectis Pharma, Inc.Common StockBENTSUR RONPurchase
Nov 5, 2025Nuvectis Pharma, Inc.Common StockSanchez JuanPurchase
Nov 5, 2025Nuvectis Pharma, Inc.Common StockKaplan Matthew L.Purchase
Sep 22, 2025Nuvectis Pharma, Inc.Common StockSanchez JuanStock award
Oct 27, 2025Nuvectis Pharma, Inc.Common StockMosseri Marlio CharlesPurchase
Oct 24, 2025Nuvectis Pharma, Inc.Common StockMosseri Marlio CharlesPurchase
Oct 23, 2025Nuvectis Pharma, Inc.Common StockMosseri Marlio CharlesPurchase

Only transactions on this page are shown. Date windows end on the latest transaction date in this sample. Joint filings may appear on more than one row. Sales are not included. Share-price charts use a separate data source.

Share price & reported acquisitions

Daily closing prices from a separate source. The date window above also filters prices; reporting-owner and transaction-type selections filter the markers.

Price history is not available

Market-price history is not connected yet.

NVCT · Currency not specified. A marker uses that day's closing price, not the reported transaction price. No price is substituted for a missing trading day.

Reported acquisitions

Filing-date filters apply to the list and timeline. The summary above uses transaction dates.

Reset
Reported insider acquisitions, ordered by filing date, newest first. Currency is shown only when reported.
Filed / transactedReporting ownersType / securityQuantityPrice / reference valueDetails
Trade:
BENTSUR RONChairman & CEO · Director · 10% owner
PurchaseCommon StockNon-derivative security · Code P5,0005.72Value: 28,600Currency not specifiedView ↗
Trade:
Sanchez JuanDirector
PurchaseCommon StockNon-derivative security · Code P13,0005.79 *Value: 75,270Currency not specifiedView ↗
Trade: PurchaseCommon StockNon-derivative security · Code P11,0005.84Value: 64,240Currency not specifiedView ↗
Trade:
Sanchez JuanDirector
Stock awardCommon StockNon-derivative security · Code A30,0000Value: 0Currency not specifiedView ↗
Trade: PurchaseCommon StockNon-derivative security · Code P72,8366.28Value: 457,410.08Currency not specifiedView ↗
Trade: PurchaseCommon StockNon-derivative security · Code P35,0346.15Value: 215,459.1Currency not specifiedView ↗
Trade: PurchaseCommon StockNon-derivative security · Code P46,9006.06Value: 284,214Currency not specifiedView ↗

Reporting owners are associated with a filing. Jointly reported amounts are not allocated to individual owners. Historical coverage is still being built. Read the methodology →